IP Verse

Sk Bioscience competitive analysis

Latest oppositions filed by Sk Bioscience

Explore patent oppositions filed by Sk Bioscience against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 30, 2026
Patent NumberTitleApplicantOpposition Date
EP3576759
Methods For Production Of Capsular Polysaccharide Protein Conjugates From Streptococcus Pneumoniae Serotype 19FMERCK SHARP & DOHMEJun 24, 2026
EP3678654
Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein ConjugatesMERCK SHARP & DOHMEMar 18, 2025
EP3583947
Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates ThereofPFIZERJul 11, 2024
EP3096785
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses ThereofPFIZERJun 9, 2021
EP2676679
Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic CompositionsWYETHOct 2, 2019
EP3017827
Pneumococcal Polysaccharide Conjugate VaccineGLAXOSMITHKLINEAug 6, 2019

Latest PTAB cases involving Sk Bioscience

Discover the latest PTAB cases involving Sk Bioscience, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sk Bioscience with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 30, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SK BIOSCIENCE6 - - -
GLAXOSMITHKLINE2912063
MERCK SHARP & DOHME2247615
PFIZER54984412